Open Access<p>Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis</p>
Author(s) -
Vladimir Zah,
J Pelivanovic,
Simona Tatović,
Djurdja Vukicevic,
M Imro,
J. Ruby,
David Hurley
Publication year - 2020
Publication title -
clinicoeconomics and outcomes research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.591
H-Index - 27
ISSN - 1178-6981
DOI - 10.2147/ceor.s269957
Subject(s) - dupuytren's contracture , medicine , propensity score matching , collagenase , contracture , surgery , emergency medicine , biology , biochemistry , enzyme
Studies examining differences in US healthcare resource utilization (HCRU) and associated healthcare costs between collagenase clostridium histolyticum (CCH) and fasciectomy for Dupuytren contracture (DC) are limited. This study evaluated US HCRU and direct healthcare cost for the treatment of DC in privately insured patients using insurance claims.